During biosynthesis, class I molecules of the major histocompatibility complex exist as complexes of the polymorphic a and ( chains in association with trimers of the invariant chain (Ii). The 
Class II molecules encoded by the major histocompatibility complex (MHC) bind antigenic peptides and present them to CD41 T cells (reviewed in ref. 1) . Unlike class I molecules, which have a strict requirement for interaction with peptide for proper folding and efficient transit out of the endoplasmic reticulum (2, 35) , class II molecules do not encounter peptides until a much later stage in their biosynthesis. In general, peptides bind to class II in an acidic, endosomal compartment (3) . Prior to that time, the class II a and ( chains are associated with a third, nonpolymorphic protein, the invariant chain (Ii) (4) . The a(3Ii complex binds antigenic peptides poorly in vitro (5, 6) . Presentation of peptide antigen by antigen-presenting cells expressing the surface a(3i complex is reduced (7) . In addition, Ii is extremely sensitive to the proteases found in endosomes (8, 9) . Therefore, Ii may serve to prevent the class II molecule from binding self peptides until it reaches the endosome. Whether this is accomplished by direct competition with the putative peptide binding site or by altering the class II conformation is unknown. Ii also serves as an intracellular chaperone for the a and ( chains (10, 36) . The localization of newly synthesized class II in endosomes is dependent on the presence of Ii (11, 12) . This endosomal targeting or retention signal has been localized in the amino-terminal (cytoplasmic) portion of Ii (11, 13) .
Evidence from the use of class I/class II hybrids suggests that the interaction between class II and Ii is controlled by the membrane-distal portion of the class II molecule (14) . However, no specific portion of class II has been identified as the Ii binding site. Based on limited amino acid sequence homology between Ii and certain staphylococcal enterotoxins, it has been suggested that both the toxins and Ii share the same class II-binding domain (15) . These toxins belong to a group of proteins known as microbial superantigens (16) . They are capable of moderate-to high-affinity binding to many human and mouse class II molecules and cause polyclonal T-cell activation based on T-cell antigen receptor (TCR) (3-chain variable gene segment (Va) usage. The binding sites for several staphylococcal toxins have been identified. The structurally similar toxins staphylococcal enterotoxins A and E (SEA and SEE) bind to a conserved region of the class II ( chain including the histidine residue at position 81 (17, 18) . Toxic shock syndrome toxin (TSST) requires sequences in the al domain for high-affinity binding to human class II (19) and in both the al and (31 domains of mouse class II (20) . Finally, the residues necessary for binding of antigenic peptides to class II have been shown to be distinct from those involved in toxin binding (21) .
We have recently developed a series of transfected human fibroblast cell lines expressing surface a(3Ii complexes (7) . These cells were transfected with Ii cDNA coding for molecules lacking the amino-terminal 15 or 20 residues. All the detectable HLA-DR a and ( chains expressed on the surface of these cells were present as part of an a(31i trimer. The ability of these cells to present antigenic peptide was reduced by a factor of =50. These transfected cells expressing surface af3Ii complexes provided the opportunity to directly test whether the binding sites for Ii and for superantigens were similar or distinct. Here we report on the ability of cells expressing class II a(3Ii complexes to bind staphylococcal superantigens and stimulate T cells.
MATERIALS AND METHODS
Cells. The 4N5 cell line is a cloned, HLA-DR1-expressing transfectant ofthe class II-and Ii-negative human fibroblastic cell line Ml (22) . The 4N5-Ii, 4N5-IiAl5, and 4N5-IiA20 cell lines are stable transfectants of4N5 expressing the full-length (p33) human Ii or an Ii lacking the amino-terminal 15 (Al15) or 20 (A20) amino acids (7) . Cells were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum, 2 mM glutamine, 10 mM Hepes (pH 7.4), and antibiotics. Transfectants were kept in selective medium with either G418 (0.5 mg/ml, dry weight), for 4N5, or G418 plus Abbreviations: Ii, invariant chain; MHC, major histocompatibility complex; SEA to SEE, staphylococcal enterotoxins A to E; TCR, T-cell antigen receptor; TSST, toxic shock syndrome toxin. tTo whom reprint requests should be addressed.
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Toxin Binding. The staphylococcal toxins SEA, SEB, SEC3, SED, SEE, TSST, and exfoliative toxin were obtained from Toxin Technology (Sarasota, FL). Binding of the various toxins to cells expressing DR1 or DR1 plus Ii was assayed as described (18) . Simultaneous measurement of HLA-DR expression was determined by incubating the cells with the monoclonal antibody L243 followed by fluoresceinated goat anti-mouse IgG. The cells were also stained for the surface expression of wild-type or truncated human Ii. The cells were first stained with the monoclonal antibody POP.14.3 (IgM) (23), followed by rabbit anti-mouse 1L chain, and then fluoresceinated goat anti-rabbit IgG. Microcytofluorimetry was performed on a FACScan (Becton Dickinson).
T-CeU Assays. Purified T cells were isolated from peripheral blood of normal human volunteers (18 quantified with the AMBIS radioanalytic imaging system (AMBIS Systems, San Diego). The specificity of these amplifications was confirmed by electrophoresis of samples of products in agarose gels, transfer to nylon membranes, and probing as described above. All V-region products detectable on slot blots produced a single band of the correct size on the agarose gel blots. The data are expressed as the mean of the triplicate samples ofeach V, amplification divided by the sum of the 22 Vp amplifications. RESULTS Ii Does Not Block Binding of Staphylococcal Toxins to HLA-DR. The binding of the staphylococcal toxins SEA, SEB, SED, and TSST was tested on transfected human fibroblasts expressing the DR1 af3 heterodimer alone (4N5), DR1 a(3 together with the major p33 form of Ii (4N5-Ii), or surface apli complexes (4N5-IiA20) (Fig. 1) . Ii is synthesized in excess over the a and P chains in both 4N5-Ii and 4N5-IiA20 and is present intracellularly at comparable levels in each cell type. In 4N5-IiA20, the amino-terminally truncated Ii does not dissociate from the a and ( chains ofDR and is present at the cell surface as part of a stable ah31i complex (7) . The level of DR at the cell surface is increased -2-fold on cells transfected with Ii or IiA2O ( Fig. 1 A, F , and K). The exact mechanism for this difference is unknown but may represent differences in either transit of class II out of the endoplasmic reticulum or stability of the molecule.
The surface expression oftransfected Ii is also shown in Fig.  1 A, F, and K. There is a small amount of wild-type Ii at the cell surface. This is detected with POP.I, an IgM monoclonal antibody, with a subsequent two-step signal amplification. Hence, the true level of surface Ii is actually much less than that of the class II aB dimers and in accordance with other studies demonstrating a low level ofcell surface Ii (26) . A small fraction of Ii molecules in 4N5-Ii has thus escaped endosomal degradation. In contrast, loss ofthe endosomal targeting signal of Ii leads to a level of IiA2O on the cell surface that is '-100 times that seen with full-length Ii. This includes both Ii that is complexed to class II and an excess of free Ii (7) . SEA (Fig. 1 B , G, and L), SEB (C, H, and M), SED (D, I, and N), and TSST (E, J, and 0) bind to all three cell types. For SEA, SEB, and SED, the level of binding increases 10 100 1000 10 100 1000 10 100 1000 10 100 1000 10 100 1000
Relative Fluorescence Intensity (Fig. 3) . The 4N5 cells are not defective in T-cell stimulation, as they efficiently present synthetic peptide to E1.9 ( Fig. 3 and ref. 7) . The 4N5 cells do present SEA to another H3-specific T-cell clone (data not shown) and to polyclonal T-cell population (Fig. 2) . This The reduced binding of TSST in the presence of surface Ii provides additional evidence for the distinction among different toxins in the way they interact with class II. SEA and SEE bind to a conserved region in the a-helical portion of the DR /3 chain (18, 27) , while TSST interacts with sequences in the al domain of DR and in the a-helices of both a and /8 chains in mouse Ia (19, 20) . However, there may be a degree of overlap among these sites as demonstrated by partial cross-inhibition of binding (28) . In this study, the binding of SEA and SEE was unaffected by the presence of surface Ii. TSST binding was diminished but not abrogated on 4N5-IiA20. This suggests that Ii is not physically associated with a large region of the a-helices of either the al or the /31 domain. Ii would either have to bind at the "end" of the a-helices, away from the toxin binding sites, or extend directly into the peptide binding site.
In addition to their binding to afpli complexes, the staphylococcal toxins retained their ability to stimulate T cells in the presence of IiA20. This suggests that Ii binds to aB molecules in such a way that TCR recognition of MHC molecules can still occur. An alternative interpretation, however, is that MHC/TCR contacts are not necessary during T-cell stimulation by superantigen and that toxin interaction with Vp was insensitive to the Ii chain bound to aB. A role for MHC structure in superantigen-mediated T-cell responses was suggested by a study of multiple class II isotypes and alleles (27) . On the other hand, certain CD8+ T-cell clones can be stimulated by class II-negative cells by high concentrations of staphylococcal toxins, suggesting that MHC/TCR interactions may not be essential (29) . MHC/TCR interactions during SEA-mediated stimulation was obtained by using the DR1-restricted, antigen-specific T-cell clone E1.9. This clone failed to respond to SEA when bound to ac3 chains expressed in a cell line lacking Ii, even though it recognized a specific peptide presented by the same cells. E1.9 is efficiently stimulated by SEA in association with class II on a human B-cell line (18) or with a transfected line expressing af3 chains in the presence of Ii (Fig. 3) . The different conformations of af3 chains expressed in the presence or the absence of Ii had previously been suggested by antibody reactivity, ability to load peptides, and heterodimer stability (30, 31) . The failure of clone E1.9 to recognize SEA bound to DR on 4N5 suggests that class II molecules that are synthesized and mature in the absence of Ii differ substan- Because these endogenous superantigens also stimulate T cells via Vi, it is likely that they bind to class II in a manner similar to exogenous superantigens. Thus, it is quite possible that endogenous superantigens bind to class II molecules directly in the exocytic pathway, prior to the dissociation of T-cell clone E1.9 fails to respond to SEA bound to 4N5. Rested E1.9 cells (DR1-restricted, human T-cell clone specific for residues 307-318 of influenza hemagglutinin) were cocultured with 4N5 (n), 4N5-Ii (o), or 4N5-IiA20 (A) cells that had been 51Cr-labeled and pulsed with either SEA or hemagglutinin-(307-318) peptide. Cytotoxic T-cell activity was measured by 51Cr release 8 hr later. The specific lysis obtained with SEA-pulsed target cells is expressed as a percentage of the specific lysis obtained with saturating hemagglutinin-(307-318) peptide (relative lysis). At saturating peptide concentrations, all three target cells are recognized by the clone E1.9 (7) . Data represent the mean of triplicate determinations.
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Ii from a,( in endosomes. Because of the importance of potential pathogen-encoded superantigens in understanding disease, many human pathogens are currently being screened for superantigen activity. The search for such superantigens must obviously include endogenous proteins.
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